Paul Knight
Stock Analyst at Keybanc
(2.38)
# 2,633
Out of 5,090 analysts
139
Total ratings
46.09%
Success rate
-1.57%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Maintains: Overweight | $325 → $350 | $280.23 | +24.90% | 12 | Oct 24, 2025 | |
| XGN Exagen | Maintains: Overweight | $12 → $15 | $7.20 | +108.33% | 7 | Oct 14, 2025 | |
| LFCR Lifecore Biomedical | Initiates: Sector Weight | n/a | $7.63 | - | 1 | Sep 4, 2025 | |
| ATR AptarGroup | Initiates: Overweight | $220 | $121.91 | +80.46% | 1 | Sep 4, 2025 | |
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.54 | +57.23% | 9 | Aug 6, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $112.50 | +20.00% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.76 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $61.68 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $394.81 | +16.51% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.43 | - | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $8 | $3.98 | +101.01% | 1 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $132 → $145 | $100.79 | +43.86% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $190.01 | +121.04% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $99.70 | +130.69% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.46 | +29.62% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $38.65 | -6.86% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $226.25 | +37.02% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $164.98 | +33.35% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $572.77 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $22.11 | +67.35% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $3.70 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.80 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $145.49 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $35.05 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $10.93 | +265.97% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $184.31 | +62.77% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $225.85 | +10.69% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $120.50 | +265.98% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $142.51 | +65.60% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $81.40 | +21.62% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $11.26 | +388.45% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $44.61 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $77.63 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $128.96 | - | 5 | Oct 23, 2017 |
West Pharmaceutical Services
Oct 24, 2025
Maintains: Overweight
Price Target: $325 → $350
Current: $280.23
Upside: +24.90%
Exagen
Oct 14, 2025
Maintains: Overweight
Price Target: $12 → $15
Current: $7.20
Upside: +108.33%
Lifecore Biomedical
Sep 4, 2025
Initiates: Sector Weight
Price Target: n/a
Current: $7.63
Upside: -
AptarGroup
Sep 4, 2025
Initiates: Overweight
Price Target: $220
Current: $121.91
Upside: +80.46%
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.54
Upside: +57.23%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $112.50
Upside: +20.00%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.76
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $61.68
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $394.81
Upside: +16.51%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.43
Upside: -
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $3.98
Upside: +101.01%
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $100.79
Upside: +43.86%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $190.01
Upside: +121.04%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $99.70
Upside: +130.69%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.46
Upside: +29.62%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $38.65
Upside: -6.86%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $226.25
Upside: +37.02%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $164.98
Upside: +33.35%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $572.77
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $22.11
Upside: +67.35%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $3.70
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.80
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $145.49
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $35.05
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $10.93
Upside: +265.97%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $184.31
Upside: +62.77%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $225.85
Upside: +10.69%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $120.50
Upside: +265.98%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $142.51
Upside: +65.60%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $81.40
Upside: +21.62%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $11.26
Upside: +388.45%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $44.61
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $77.63
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $128.96
Upside: -